Quantum chemical modeling of the inhibition mechanism of monoamine oxidase by oxazolidinone and analogous heterocyclic compounds

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 1, 2014, Pages 81-86

  Erdem, Safiye Saǧ ^a   Özpinar, Gül Altinbaş ^b   Boz, Ümüt ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b BURSA TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Adduct dissociation; Adduct stability; Dihydrofuranone; Enzyme inhibition; Oxazolidinone; Pyrrolidinone

Indexed keywords

AMINE; AMINE OXIDASE (FLAVIN CONTAINING); CYSTEINE; HETEROCYCLIC COMPOUND; NEUROTRANSMITTER; OXAZOLIDINONE DERIVATIVE;

AB INITIO CALCULATION; ARTICLE; COVALENT BOND; DENSITY FUNCTIONAL THEORY; DRUG INTERMITTENT THERAPY; ELIMINATION REACTION; ENERGY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME STABILITY; MEASUREMENT; OXIDATION; PRIORITY JOURNAL; QUANTUM CHEMISTRY; STRUCTURE ACTIVITY RELATION;

HETEROCYCLIC COMPOUNDS; MODELS, MOLECULAR; MONOAMINE OXIDASE INHIBITORS; OXAZOLIDINONES; QUANTUM THEORY;

EID: 84878714279     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.753882     Document Type: Article

References (47)

1. Lu X, Rodrigues M, Gu W, Silverman RB. Inactivation of mitochondrial monoamine oxidase B by methylthio-substituted benzylamines. Bioorg Med Chem 2003;11:4423-30
2. Ives JL, Heym J. Antidepressant agents. Annu Rep Med Chem 1989;24:21-9
3. Tetrud VW, Langston JW. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science 1989;245:519-22
4. Silverman RB. Radical ideas about monoamine-oxidase. Acc Chem Res 1995;28:335-42, and the references therein
5. Haefely WE, Burkard WP, Cesura AM, et al. Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology 1992;106:6-14
6. Cesura AM, Fletcher A. The new generation of monoamine oxidase inhibitors. Prog Drug Res 1992;38:171-297
7. Binda C, Newton-Vinson P, Hubalek F, et al. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 2002;9:22-6
8. Scrutton NS. Chemical aspects of amine oxidation by flavoprotein enzymes. Nat Prod Rep 2004;21:722-30
9. Edmondson DE, Mattevi A, Binda C, Hubalek F. Structure and mechanism of monoamine oxidase. Curr Med Chem 2004; 11:1983-93
10. Fitzpatrick PF. Oxidation of amines by flavoproteins. Arch Biochem Biophys 2010;493:13-25
11. Dunn RV, Munro AW, Turner NJ, et al. Tyrosyl radical formation and propagation in flavin dependent monoamine oxidases. Chem BioChem 2010;11:1228-31
12. Erdem SS, Karahan Ö , Yildiz I, Yelekçi K. A computational study on the amine-oxidation mechanism of monoamine oxidase: Insight into the polar nucleophilic mechanism. Org Biomol Chem 2006; 4:646-8
13. Akyüz MA, Erdem SS, Edmondson DE. The aromatic cage in the active site of monoamine oxidase B: Effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine. J Neural Trans 2007;114:693-8
14. Erdem SS, Büyükmenek'se B. Computational investigation on the structure-Activity relationship of the biradical mechanism for monoamine oxidase. J Neural Trans 2011;118:1021-9
15. Miller JR, Edmondson DE. Structure-Activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry 1999; 38:13670-83
16. Silverman RB, Cesarone JM, Lu X. Stereoselective ring-opening of 1-phenylcyclopropylamine catalyzed by monoamine oxidase-b. J Am Chem Soc 1993;115:4955-61
17. Silverman RB, Zelechonok Y. Evidence for a hydrogen-Atom transfer mechanism or a proton fast electron-Transfer mechanism for monoamine-oxidase. J Org Chem 1992;57:6373-4
18. Silverman RB, Lu X, Zhou JJP, Swihart A. Monoamine-oxidase b-catalyzed oxidation of cinnamylamine 2,3-oxide-further evidence against a nucleophilic mechanism. J Am Chem Soc 1994;116:11590-1
19. Silverman RB, Ding CZ, Borillo JL, Chang JT. Mechanism-based enzyme inactivation via a deactivated cyclopropane intermediate. J Am Chem Soc 1993;115:2982-3
20. Wang X, Silverman RB. 2-(Iodoethenyl)benzyl amines as potential probes for radical intermediates formed during monoamine oxidasecatalyzed oxidations. J Org Chem 1998;63:7357-63
21. Silverman RB, Zhou JP, Eaton PE. Inactivation of monoamineoxidase by (aminomethyl)cubane-1st evidence for an alpha-Amino radical during enzyme catalysis. J Am Chem Soc 1993;115:8841-2
22. Silverman RB. Electron transfer chemistry of monoamine oxidase. In: Mariano PS, ed. Advances in electron transfer chemistry. Greenwich: JAI Press; 1992:177-213
23. Silverman RB, Hiebert CK. Inactivation of monoamine oxidase-A by the monoamine oxidase-b inactivators 1-phenylcyclopropylamine, 1- benzylcyclopropylamine, and n-cyclopropyl-Alpha-methylbenzylamine. Biochemistry 1988;27:8448-53
24. Zhong BY, Silverman RB. Identification of the active site cysteine in bovine liver monoamine oxidase B. J Am Chem Soc 1997; 119:6690-1
25. Binda C, Hubalek F, Li M, et al. Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane. FEBS Lett 2004;564:225-8
26. de Colibus L, Binda C, Lustig A, et al. Three-dimensional structure of human monoamine oxidase A (MAO-A): Relation to the structures of rat MAO-A and human MAO-B. Proc Natl Acad Sci 2005; 102:12684-9
27. Son SY, Ma J, Kondou Y, et al. Structure of human monoamine oxidase A at 2.2-A ' resolution: The control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci 2008;105:5739-44
28. Ma J, Yoshimura M, Yamashita E, et al. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J Mol Biol 2004;338:103-14
29. Lu X, Rodriguez M, Ji H, et al. Irreversible inactivation of mitochondrial monoamine oxidases. In: Chapman SK, Perham RN, Scrutton NS, eds. Flavins and flavoproteins. Proceedings of the 14th International Symposium; 2002 Jul 14-18; Cambridge. Berlin: Rudolf Weber; 2002:817-30
30. Vintém APB, Price NT, Silverman RB, Ramsay RR. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines. Bioorg Med Chem 2005;13:3487-95
31. Lu X, Rodriguez M, Gu W, Silverman RB. Inactivation of mitochondrial monoamine oxidase B by methylthio-substituted benzylamines. Bioorg Med Chem 2003;11:4423-30
32. Erdem SS, Yelekci K. Computer modeling of oxygen containing heptylamines as monoamine oxidase inactivators. J Mol Struct (Theochem) 2001;572:97-106
33. Borstnar R, Repic M, Krzan M, et al. Irreversible inhibition of monoamine oxidase B by the antiparkinsonian medicines rasagiline and selegiline: A computational study. Eur J Org Chem 2011; 2011:6419-33
34. Silverman RB, Ding CZ. Chemical-model for a mechanism of inactivation of monoamine-oxidase by heterocyclic-compounds-electronic effects on acetal hydrolysis. J Am Chem Soc 1993; 115:4571-6
35. Ding CZ, Silverman RB. Transformation of heterocyclic reversible monoamine oxidase-b inactivators into irreversible inactivators by N-methylation. J Med Chem 1993;36:3606-10
36. Ding CZ, Silverman RB. 4-(Aminomethyl)-1-Aryl-2-pyrrolidinones, a new class of monoamine oxidase-b inactivators. J Enzyme Inhib 1992;6:223-31
37. Ding CZ, Silverman RB. Selective inactivation of monoamineoxidase-b by aminoethyl 3-chlorobenzyl ether. Bioorg Med Chem Lett 1993;3:2077-8
38. Lu XL, Silverman RB. Monoamine oxidase B-catalyzed reactions of cis-And trans-5-Aminomethyl-3-(4-methoxyphenyl)dihydrofuran-2(3H)-ones. Evidence for a reversible redox reaction. J Am Chem Soc 1998;120:10583-7
39. Ding CZ, Silverman RB. 5-(Aminomethyl)-3-Aryldihydrofuran-2(3H)-ones, a new class of monoamine oxidase-B inactivators. J Med Chem 1992;35:885-9
40. Silverman RB, Ding CZ, Gates KS. Design and mechanism of monoamine oxidase inactivators from a chemical perspective. In: Testa B, Kyburz E, Fuhrer W, Giger R, eds. Perspectives in medicinal chemistry. Basel: Verlag Helvetica Chimica Acta; 1993:73
41. Jones TZE, Fleming P, Eyermann CJ, et al. Orientation of oxazolidinones in the active site of monoamine oxidase. Biochem Pharmacol 2005;70:407-16
42. Spartan 04, Wavefunction Inc., Irvine, CA, USA. Available from: Http://www.wavefun.com
43. Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 03 revision D.01. Wallingford, CT: Gaussian Inc.; 2004
44. Gonzalez C, Schlegel HB. An improved algorithm for reaction-path following. J Chem Phys 1989;90:2154-62
45. Chambers CC, Hawkins GD, Cramer CJ, Truhlar DG. A model for aqueous solvation based on class IV atomic charges and first-solvation-shell effects. J Phys Chem B 1996;100: 16385-98
46. Steinfield JI, Francisco JS, Hase WL. Chemical kinetics and dynamics. Upper Saddle River (NJ): Prentice Hall; 1989:321-3
47. Li M, Binda C, Mattevi A, Edmondson DE. Functional role of the ''Aromatic Cage'' in human monoamine oxidase B: Structures and catalytic properties of Tyr435 mutant proteins. Biochemistry 2006;45:4775-84